Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Medical therapy in ulcerative colitis].

K Motegi1, K Nagasako, H Nogawa

  • 1Gunma Cancer Center.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|November 26, 1999
PubMed
Summary

Salazosulfapyridine (SASP) and 5-aminosalicylic acid (5-ASA) treat mild to moderate ulcerative colitis. For severe cases, glucocorticoids and surgery may be necessary.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coping strategies and risk of cardiovascular disease incidence and mortality: the Japan Public Health Center-based prospective Study.

European heart journal·2016
Same author

DNA demethylating agent decitabine increases AQP5 expression and restores salivary function.

Journal of dental research·2012
Same author

Differential expression of platelet-derived endothelial cell growth factor (thymidine phosphorylase) in nonpolypoid and polypoid lesions of the colon.

International journal of oncology·2011
Same author

Structural equation modeling of the relationship of bone mineral density and its risk factors in Japanese women.

Environmental health and preventive medicine·2011
Same author

Application of PDT for Uterine Cervical Cancer.

Diagnostic and therapeutic endoscopy·2008
Same author

Preservation of mitochondrial function may contribute to cardioprotective effects of Na+/Ca2+ exchanger inhibitors in ischaemic/reperfused rat hearts.

British journal of pharmacology·2007

Area of Science:

  • Gastroenterology
  • Pharmacology

Context:

  • Ulcerative colitis (UC) management.
  • Mild to moderate UC therapy options.

Purpose:

  • Summarize current therapeutic strategies for ulcerative colitis.
  • Highlight medication efficacy and side effect profiles.
  • Outline treatment escalation for refractory cases.

Summary:

  • Salazosulfapyridine (SASP) and 5-aminosalicylic acid (5-ASA) are first-line treatments for mild to moderate active ulcerative colitis.
  • 5-ASA offers a similar efficacy to SASP but with fewer side effects due to the absence of the sulfa moiety.
  • Glucocorticoids are beneficial for moderate to severe UC, administered orally or as enemas for proctitis/left-sided colitis, often in conjunction with SASP or 5-ASA.
  • Hospitalization and intensive glucocorticoid therapy are indicated for refractory symptoms.
  • Total colectomy with ileo-anal anastomosis (IAA) is a consideration for acutely ill patients unresponsive to medical management, necessitating early surgical consultation.

Impact:

  • Provides a concise overview of ulcerative colitis treatment algorithms.
  • Informs clinical decision-making for managing UC patients.
  • Emphasizes the importance of tailored therapeutic approaches based on disease severity.

Related Experiment Videos